| Literature DB >> 31713353 |
Yunpu He1, Liheng Huang2, Yuqian Zheng3, Jian-Huan Chen3,4, Shijie Tang1.
Abstract
BACKGROUND: Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is a common congenital malformation in the world. Both environment and genetics are involved with the etiology of the disease. Genome-wide association studies have identified two single nucleotide polymorphisms (SNPs) at chromosome 20q12 to be associated with NSCL/P. The current study aimed to explore the association of the two SNPs at 20q12 with NSCL/P and different subtypes in a Southern Chinese Han cohort.Entities:
Keywords: 20q12.; nonsyndromic cleft lip with or without cleft palate (NSCL/P); single nucleotide polymorphism (SNP)
Year: 2019 PMID: 31713353 PMCID: PMC6978266 DOI: 10.1002/mgg3.1028
Source DB: PubMed Journal: Mol Genet Genomic Med ISSN: 2324-9269 Impact factor: 2.183
Sex and age comparisons between NSCL/P patients and controls
| Group | Age (Mean ± | Sex | Phenotype | Total | |||
|---|---|---|---|---|---|---|---|
| Male | Female | CLO | CLP | CPO | |||
| NSCL/P | 6.5 ± 7.0 | 257 | 128 | 73 | 256 | 56 | 385 |
| Control | 36.7 ± 19.5 | 208 | 240 | None | None | None | 448 |
Abbreviations: CLO, cleft lip only; CLP, cleft lip and palate; CPO, cleft palate only.
Sequences of genotyping for the two SNPs in at chromosome 20q12
| Locus | SNP (Assay ID) | Sequence | VIC | FAM |
|---|---|---|---|---|
| 20q12 | rs6072081 | ACAGTGGTAGCCGGTAATCAACCGG[A/G] | A | G |
| (C__29493999_10) | TTGGTCACACACGCAGTGCCCTACA | |||
| rs17820943 | GGCAGCATGGCTCAATTCAGTGCTC[C/T] | C | T | |
| (C__27165669_10) | CTGGCCTAGTCACAGCTTTGGGAAG |
Hardy–Weinberg equilibrium in controls
| Chromosome | SNPs ID | ObsHET | PredHET | HWpval | MAF | Alleles |
|---|---|---|---|---|---|---|
| 20q12 | rs6072081 | 0.522 | 0.493 | 0.246 | 0.439 | A:G |
| rs17820943 | 0.523 | 0.495 | 0.283 | 0.452 | C:T |
Abbreviations: HWpval, Hardy–Weinberg equilibrium; ObsHET, Observe the heterozygosity; PredHET, Predict heterozygosity; P‐value, MAF: Less allele frequency.
Comparison of genotypes and alleles between NSCL/P patients and controls
| SNP | NSCL/P ( | Control ( | P‐value | OR (95% CI) | |
|---|---|---|---|---|---|
| rs6072081 | AA | 165 | 135 | 0.008 | 0.686 (0.519–0.908) |
| AG | 216 | 236 | 0.008 | 0.596 (0.407–0.875) | |
| GG | 49 | 80 | 0.001 | 0.731 (0.604–0.885) | |
| A | 547 | 506 | |||
| G | 313 | 396 | |||
| rs17820943 | CC | 160 | 129 | 0.007 | 0.676 (0.510–0.897) |
| CT | 218 | 236 | 0.004 | 0.584 (0.402–0.848) | |
| TT | 52 | 86 | 0.001 | 0.722 (0.597–0.873) | |
| C | 540 | 494 | |||
| T | 322 | 408 |
The dominant model.
Recessive model.
Allelic model.
Comparison of genotypes and alleles between NSCL/P with clinical subtypes and controls
| Subtype | Genotype | Allele | P | P | P | OR (95% CI) | OR (95% CI) | OR (95% CI) |
|---|---|---|---|---|---|---|---|---|
| rs6072081 | AA/AG/GG | A/G | ||||||
| CLO ( | 21/43/9 | 85/61 | 0.813 | 0.245 | 0.638 | 0.936 (0.543–1.616) | 1.546 (0.739–3.235) | 1.089 (0.764–1.552) |
| CLP ( | 108/119/28 | 335/175 | 0.001 | 0.015 | 4.52 × 10–4 | 0.587(0.426–0.808) | 0.567 (0.358–0.900) | 0.669 (0.534–0.838) |
| CPO ( | 17/31/8 | 65/47 | 0.973 | 0.507 | 0.703 | 1.011(0.552–1.849) | 0.767 (0.349–1.683) | 0.925 (0.622–1.378) |
| Control ( | 135/233/80 | 503/393 | ||||||
| rs17820943 | CC/CT/TT | C/T | ||||||
| CLO ( | 19/45/9 | 83/63 | ||||||
| CLP ( | 109/117/29 | 335/175 | 1.71 × 10–4 | 0.007 | 6.7 × 10–5 | 0.542 (0.393–0.747) | 0.54 (0.344–0.849) | 0.633 (0.506–0.793) |
| CPO ( | 14/33/9 | 61/51 | 0.553 | 0.573 | 0.946 | 1.213 (0.641–2.297) | 0.806 (0.380–1.708) | 1.014 (0.683–1.504) |
| Control ( | 129/233/86 | 491/405 |
The dominant model
Recessive model
Allelic model.